Psychiatric Times introduces new information on anxiety disorders

UBM Medica US announces that Psychiatric Times, a leading online community for mental health professionals, introduces the latest information on anxiety disorders.

A new Special Report reviews the latest pharmacological strategies for anxiety, comorbid anxiety and schizophrenia, TMS, and managing anxiety in the medically ill. Featured articles include:

  • Pharmacological Strategies for Generalized Anxiety Disorder: Jennifer A. Reinhold, PharmD, BCPS, BCPP reviews treatment approaches to GAD, a highly prevalent, chronic, debilitating, relapsing, and often underdiagnosed anxiety disorder.
  • Treating Comorbid Anxiety Disorders in Patients With Schizophrenia: A New Pathway: Amelie M. Achim, PhD, Stephanie Sutliff, MSc, and Marc-Andre Roy, MD, MSc stress the importance of identifying comorbid anxiety disorders as potential treatment targets that may contribute to more positive outcomes for patients with schizophrenia.
  • Does TMS Hold Promise for Generalized Anxiety Disorder?: Available data suggest that transcranial magnetic stimulation holds promise as a treatment for anxiety. Gretchen J. Diefenbach, PhD and John W. Goethe, MD take a look at what we know.

UBM Medica US


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Study explores how corporal punishment may impact neural systems to produce adverse effects